MAM
BOUNCE Inc onboards Tarandeep Singh Sekhon as chief business officer
Mumbai: KidZania’s former marketing director, Tarandeep Singh Sekhon, has joined freestyle sports company BOUNCE Inc. as its new chief business officer for India.
Sekhon, with over two decades of experience in the entertainment industry, is now all set to drive business growth at BOUNCE and bring his expertise to strengthen the brand in India. He will be responsible for sales, marketing, and strategic development for BOUNCE in the country.
After a successful seven-year stint at KidZania, Sekhon was responsible for building brand affinity and driving footfalls to its centers. Prior to KidZania, he led the marketing mandate for EsselWorld, Water Kingdom, and Fame Cinemas.
BOUNCE Inc. is an international brand with a presence across 16 countries, and in India, it has set up the country’s largest trampoline park, combining elements of the world’s most exciting freestyle activities in a 40,000 sq. ft. indoor arena.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
